All News

For patients with adenocarcinoma of the esophagus and esophagogastric junction, chemoradiotherapy and chemotherapy improved survival versus surgery alone.

I’ve recently started on chemotherapy pills instead of infusions and the bitterness reminds me to accept not only the bitterness of the pill, but in life too.

First-line Keytruda plus chemotherapy is the new standard of care for patients with advanced pleural mesothelioma after the previous treatment strategy of chemotherapy alone.

In some patients with head and neck cancer, those who require dental care after cancer treatment may face financial burdens because of out-of-pocket costs.

Several colleagues, patients and caregivers nominated Jill May, B.S.N., RN, OCN, for the 2024 Extraordinary Healer Award for her dedicating to caring for those with gastrointestinal cancers.

The biologics license application seeks potential approval of a Darzalex Faspro-based regimen for newly diagnosed multiple myeloma ineligible for transplant.

Distance relapse-free survival was maintained in patients with pMMR locally advanced rectal cancer through non-operative management of the disease.

Patients with muscle-invasive bladder cancer experienced safe medical and surgical treatment with the NURE-combo.

Research has shown that among patients with advanced non-small cell lung cancer, early palliative care delivered by video is as effective as in-person care.

As a survivor of acute myeloid leukemia, some things are no longer going to be normal, but who wants to be normal?

From good news for a rock star to the deaths of stage and screen stars, here’s what’s happening in the cancer space this week.

Just like how Christmas decorations creep into November before Thanksgiving, I hope Pinktober does not creep into September.

Two months after giving birth to my daughter, I noticed something was unusual, which led to my diagnosis of anaplastic oligodendroglioma.

An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.

Reflecting on the pain I experienced before my diagnosis of multiple myeloma, I realized how important it was to pay attention to the related symptoms.

The Food and Drug Administration has approved Opdivo before and after surgery for some with non-small cell lung cancer.

The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic HER2-low or -ultralow breast cancer.

Receiving perioperative Opdivo for non-small cell lung cancer showed event-free survival benefits compared with placebo.

Among patients with HR+/HER2+ breast cancer, Herceptin and Perjeta plus endocrine therapy proved to be beneficial without chemotherapy.

Researchers are advising against the interruption of treatment with Gleevec among patients with advanced gastrointestinal stromal tumors.

After recently losing my aunt, I realized that cancer has given me a new perspective on life, which reminds me that every day has meaning.

Patients with soft tissue sarcomas showed improved functional results, quality of life and fewer side effects when treated with RT-therapy.

An expert explains study findings that associate a longer time until postsurgical melanoma recurrence with improved progression and survival.

Keytruda continued to improve survival versus Yervoy in unresectable stage 3 or 4 melanoma in long-term follow-up data.

For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who need more options.

As a breast cancer survivor, I’ve learned to navigate the annual sea of pink, but I don’t like it.

Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid cancer and breast cancer.

Fotivda monotherapy may show better outcomes in second-line therapy than the combination of Opdivo and Fotivda in metastatic kidney cancer.

Benmelstobart plus anlotinib significantly improved survival versus Sutent in the first-line treatment of advanced renal cell carcinoma.

I invited my family to gather with me and celebrate four years of being cancer-free.